PitchSend

Investor Presentaiton

Coloplast has strong market positions in Europe and great commercial potential outside Europe Europe Other developed Emerging Ostomy Care Continence Care Voice & Respiratory Care (Laryngectomy) Interventional Urology Wound Care Addressable market Size in DKK Growth in %* 20-21bn 4-5% 15-16bn 5-6% 1-1.5bn 8-10% 13-14bn 3-5% 24-26bn 2-4% Coloplast total 35-40% 40 - 45% market share -85% Coloplast 40-50% regional market 15-25% 45-55% 25-35% shares 45-55% 40 - 50% Hollister Key competitors convatec -forever caring- Key drivers and limiters Ageing population • Increasing access to healthcare Health care reforms • Re-use of products outside Europe 21 15 - 20% 5-10% Wellspect HEALTHCARE BARD Hollister 80-90% 80-90% 95 - 100% FAHL INHEALTH 20-25% 15-20% 5-10% • Ageing population • IC penetration potential • • Up-selling Health care reforms Commoditization • Penetrate "white-space" Reimbursement in new geographies Compliant usage • New portfolio Provox Life™ Boston Scientific Advancing science for life" COOK MEDICAL дад BD Ageing, obesity • Under penetration • Cost consciousness Clinical requirements • Less invasive/office procedures 5-10% 0-5% 5-10% convatec -forever caring- smith&nephew 3M Mölnlycke • Ageing, obesity, diabetes •New technologies • • Healthcare reforms Competition • Community treatment Coloplast

View entire presentation